This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Thiagarajan RR, Barbaro RP, Rycus PT, et al. Extracorporeal Life Support Organisation Registry International Report 2016. ASAIO J. 2017;63:60‐7.ThiagarajanRRBarbaroRPRycusPTet alExtracorporeal Life Support Organisation Registry International Report 2016ASAIO J20176360‐710.1097/MAT.000000000000047527984321Search in Google Scholar
Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016;20:387.MillarJEFanningJPMcDonaldCIMcAuleyDFFraserJFThe inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiologyCrit Care20162038710.1186/s13054-016-1570-4512504327890016Search in Google Scholar
Wang S, Krawiec C, Patel S, et al. Laboratory evaluation of hemolysis and systemic inflammatory response in neonatal non-pulsatile and pulsatile extracorporeal life support systems. Artif Organs. 2015;39:774-81.WangSKrawiecCPatelSet alLaboratory evaluation of hemolysis and systemic inflammatory response in neonatal non-pulsatile and pulsatile extracorporeal life support systemsArtif Organs2015397748110.1111/aor.1246625940752Search in Google Scholar
Rungatscher A, Tessari M, Stranieri C, et al. Oxygenator is the main responsible for leukocyte activation in an experimental model of extracorporeal circulation: a cautionary tale. Mediators Inflamm. 2015;2015:484979.RungatscherATessariMStranieriCet alOxygenator is the main responsible for leukocyte activation in an experimental model of extracorporeal circulation: a cautionary taleMediators Inflamm2015201548497910.1155/2015/484979443420226063972Search in Google Scholar
McILwain RB, Timpa JG, Kurundkar AR, et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest. 2010;90:128-39.McILwainRBTimpaJGKurundkarARet alPlasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestineLab Invest2010901283910.1038/labinvest.2009.119279954919901912Search in Google Scholar
Mildner RJ, Taub N, Vyas JR, et al. Cytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failure. Biol Neonate. 2005;88:321-7.MildnerRJTaubNVyasJRet alCytokine imbalance in infants receiving extracorporeal membrane oxygenation for respiratory failureBiol Neonate200588321710.1159/00008763016113527Search in Google Scholar
Graulich J, Sonntag J, Marcinkowski M, et al. Complement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenation. Mediators Inflamm. 2002;11:69-73.GraulichJSonntagJMarcinkowskiMet alComplement activation by in vivo neonatal and in vitro extracorporeal membrane oxygenationMediators Inflamm200211697310.1080/09629350220131908178164812061426Search in Google Scholar
Doyle AJ, Hunt BJ. Current understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood components. Front Med (Lausanne). 2018;5:352..DoyleAJHuntBJCurrent understanding of how extracorporeal membrane oxygenators activate haemostasis and other blood componentsFront Med (Lausanne)2018535210.3389/fmed.2018.00352629900930619862Search in Google Scholar
Sniderman J, Monagle P, Annich GM, MacLaren G. Hematologic concerns in extracorporeal membrane oxygenation. Res Pract Thromb Haemost. 2020;4:455-468.SnidermanJMonaglePAnnichGMMacLarenGHematologic concerns in extracorporeal membrane oxygenationRes Pract Thromb Haemost2020445546810.1002/rth2.12346729266932548547Search in Google Scholar
Graulich J, Walzog B, Marcinkowski M, et al. Leukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO) Pediatr Res. 2000;48:679-84.GraulichJWalzogBMarcinkowskiMet alLeukocyte and endothelial activation in a laboratory model of extracorporeal membrane oxygenation (ECMO) Pediatr Res2000486798410.1203/00006450-200011000-0002111044491Search in Google Scholar
Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:801‐10.SingerMDeutschmanCSSeymourCWet alThe Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA2016315801‐1010.1001/jama.2016.0287496857426903338Search in Google Scholar
Beck L, Burg MC, Heindel W, Schülke C. Extracorporeal Membrane Oxygenation in Adults - Variants, Complications during Therapy, and the Role of Radiological Imaging. Rofo. 2017;189:119‐27.BeckLBurgMCHeindelWSchülkeCExtracorporeal Membrane Oxygenation in Adults - Variants, Complications during Therapy, and the Role of Radiological ImagingRofo2017189119‐27Search in Google Scholar
Sidebotham D, McGeorge A, McGuinness S, Edwards M, Willcox T, Beca J. Extracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2-technical considerations. J Cardiothorac Vasc Anesth. 2010;24:164‐72.SidebothamDMcGeorgeAMcGuinnessSEdwardsMWillcoxTBecaJExtracorporeal membrane oxygenation for treating severe cardiac and respiratory failure in adults: part 2-technical considerationsJ Cardiothorac Vasc Anesth201024164‐7210.1053/j.jvca.2009.08.00219875307Search in Google Scholar
Moldoveanu B, Otmishi P, Jani P, et al. Inflammatory mechanisms in the lung. J Inflamm Res 2009;2:1‐11.MoldoveanuBOtmishiPJaniPet alInflammatory mechanisms in the lungJ Inflamm Res20092111Search in Google Scholar
Hayashi T, Beck L, Rossetto C, et al. Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest 2004;114:270-9HayashiTBeckLRossettoCet alInhibition of experimental asthma by indoleamine 2,3-dioxygenaseJ Clin Invest2004114270910.1172/JCI2127544974915254594Search in Google Scholar
Raychaudhuri B, Fisher CJ, Farver CF, et al. Interleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophages. Cytokine. 2000;12:1348-55.RaychaudhuriBFisherCJFarverCFet alInterleukin 10 (IL-10)-mediated inhibition of inflammatory cytokine production by human alveolar macrophagesCytokine20001213485510.1006/cyto.2000.072110975994Search in Google Scholar
Pittet JF, Griffiths MJ, Geiser T, et al. TGF-beta is a critical mediator of acute lung injury. J Clin Invest 2001;107:1537-44.PittetJFGriffithsMJGeiserTet alTGF-beta is a critical mediator of acute lung injuryJ Clin Invest200110715374410.1172/JCI1196320019211413161Search in Google Scholar